Search

Your search keyword '"Bass, Anne R."' showing total 18 results
Start Over Author "Bass, Anne R." Publisher wiley
18 results on '"Bass, Anne R."'

1. 2022 American College of Rheumatology Guideline for Vaccinations in Patients With Rheumatic and Musculoskeletal Diseases

Author

Bass, Anne R., primary, Chakravarty, Eliza, additional, Akl, Elie A., additional, Bingham, Clifton O., additional, Calabrese, Leonard, additional, Cappelli, Laura C., additional, Johnson, Sindhu R., additional, Imundo, Lisa F., additional, Winthrop, Kevin L., additional, Arasaratnam, Reuben J., additional, Baden, Lindsey R., additional, Berard, Roberta, additional, Bridges, S. Louis, additional, Cheah, Jonathan T. L., additional, Curtis, Jeffrey R., additional, Ferguson, Polly J., additional, Hakkarinen, Ida, additional, Onel, Karen B., additional, Schultz, Grayson, additional, Sivaraman, Vidya, additional, Smith, Benjamin J., additional, Sparks, Jeffrey A., additional, Vogel, Tiphanie P., additional, Williams, Eleanor Anderson, additional, Calabrese, Cassandra, additional, Cunha, Joanne S., additional, Fontanarosa, Joann, additional, Gillispie‐Taylor, Miriah C., additional, Gkrouzman, Elena, additional, Iyer, Priyanka, additional, Lakin, Kimberly S., additional, Legge, Alexandra, additional, Lo, Mindy S., additional, Lockwood, Megan M., additional, Sadun, Rebecca E., additional, Singh, Namrata, additional, Sullivan, Nancy, additional, Tam, Herman, additional, Turgunbaev, Marat, additional, Turner, Amy S., additional, and Reston, James, additional

Published
2023
Full Text
View/download PDF

2. American College of Rheumatology Guidance for COVID ‐19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 5

Author

Curtis, Jeffrey R., primary, Johnson, Sindhu R., additional, Anthony, Donald D., additional, Arasaratnam, Reuben J., additional, Baden, Lindsey R., additional, Bass, Anne R., additional, Calabrese, Cassandra, additional, Gravallese, Ellen M., additional, Harpaz, Rafael, additional, Kroger, Andrew, additional, Sadun, Rebecca E., additional, Turner, Amy S., additional, Williams, Eleanor Anderson, additional, and Mikuls, Ted R., additional

Published
2022
Full Text
View/download PDF

3. American College of Rheumatology Guidance forCOVID‐19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 4

Author

Curtis, Jeffrey R., primary, Johnson, Sindhu R., additional, Anthony, Donald D., additional, Arasaratnam, Reuben J., additional, Baden, Lindsey R., additional, Bass, Anne R., additional, Calabrese, Cassandra, additional, Gravallese, Ellen M., additional, Harpaz, Rafael, additional, Kroger, Andrew, additional, Sadun, Rebecca E., additional, Turner, Amy S., additional, Williams, Eleanor Anderson, additional, and Mikuls, Ted R., additional

Published
2022
Full Text
View/download PDF

4. American College of Rheumatology Guidance for COVID‐19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 3

Author

Curtis, Jeffrey R., primary, Johnson, Sindhu R., additional, Anthony, Donald D., additional, Arasaratnam, Reuben J., additional, Baden, Lindsey R., additional, Bass, Anne R., additional, Calabrese, Cassandra, additional, Gravallese, Ellen M., additional, Harpaz, Rafael, additional, Kroger, Andrew, additional, Sadun, Rebecca E., additional, Turner, Amy S., additional, Williams, Eleanor Anderson, additional, and Mikuls, Ted R., additional

Published
2021
Full Text
View/download PDF

5. Reply

Author

Curtis, Jeffrey R., primary, Johnson, Sindhu R., additional, Anthony, Donald D., additional, Arasaratnam, Reuben J., additional, Baden, Lindsey R., additional, Gravallese, Ellen M., additional, Bass, Anne R., additional, Calabrese, Cassandra, additional, Harpaz, Rafael, additional, Kroger, Andrew, additional, Sadun, Rebecca E., additional, Turner, Amy S., additional, Williams, Eleanor Anderson, additional, and Mikuls, Ted R., additional

Published
2021
Full Text
View/download PDF

6. American College of Rheumatology Guidance for COVID‐19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 2

Author

Curtis, Jeffrey R., primary, Johnson, Sindhu R., additional, Anthony, Donald D., additional, Arasaratnam, Reuben J., additional, Baden, Lindsey R., additional, Bass, Anne R., additional, Calabrese, Cassandra, additional, Gravallese, Ellen M., additional, Harpaz, Rafael, additional, Kroger, Andrew, additional, Sadun, Rebecca E., additional, Turner, Amy S., additional, Williams, Eleanor Anderson, additional, and Mikuls, Ted R., additional

Published
2021
Full Text
View/download PDF

8. American College of Rheumatology Guidance for COVID‐19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 1

Author

Curtis, Jeffrey R., primary, Johnson, Sindhu R., additional, Anthony, Donald D., additional, Arasaratnam, Reuben J., additional, Baden, Lindsey R., additional, Bass, Anne R., additional, Calabrese, Cassandra, additional, Gravallese, Ellen M., additional, Harpaz, Rafael, additional, Sadun, Rebecca E., additional, Turner, Amy S., additional, Williams, Eleanor Anderson, additional, and Mikuls, Ted R., additional

Published
2021
Full Text
View/download PDF

12. 2015 American College of Rheumatology Workforce Study

Author

Bolster, Marcy B., primary, Bass, Anne R., additional, Hausmann, Jonathan S., additional, Deal, Chad, additional, Ditmyer, Marcia, additional, Greene, Kamilah L., additional, Monrad, Seetha U., additional, and Battafarano, Daniel F., additional

Published
2018
Full Text
View/download PDF

13. Does Education Level Mitigate the Effect of Poverty on Total Knee Arthroplasty Outcomes?

Author

Goodman, Susan M., primary, Mandl, Lisa A., additional, Mehta, Bella, additional, Navarro-Millan, Iris, additional, Russell, Linda A., additional, Parks, Michael L., additional, Dey, Shirin A., additional, Crego, Daisy, additional, Figgie, Mark P., additional, Nguyen, Joseph T., additional, Szymonifka, Jackie, additional, Zhang, Meng, additional, and Bass, Anne R., additional

Published
2018
Full Text
View/download PDF

14. The New York City Rheumatology Objective Structured Clinical Examination: Five-year data demonstrates its validity, usefulness as a unique rating tool, objectivity, and sensitivity to change

Author

Berman, Jessica R., primary, Lazaro, Deana, additional, Fields, Theodore, additional, Bass, Anne R., additional, Weinstein, Elena, additional, Putterman, Chaim, additional, Dwyer, Edward, additional, Krasnokutsky, Svetlana, additional, Paget, Stephen A., additional, and Pillinger, Michael H., additional

Published
2009
Full Text
View/download PDF

16. 2022 American College of Rheumatology Guideline for Vaccinations in Patients With Rheumatic and Musculoskeletal Diseases.

Author

Bass AR, Chakravarty E, Akl EA, Bingham CO, Calabrese L, Cappelli LC, Johnson SR, Imundo LF, Winthrop KL, Arasaratnam RJ, Baden LR, Berard R, Bridges SL Jr, Cheah JTL, Curtis JR, Ferguson PJ, Hakkarinen I, Onel KB, Schultz G, Sivaraman V, Smith BJ, Sparks JA, Vogel TP, Williams EA, Calabrese C, Cunha JS, Fontanarosa J, Gillispie-Taylor MC, Gkrouzman E, Iyer P, Lakin KS, Legge A, Lo MS, Lockwood MM, Sadun RE, Singh N, Sullivan N, Tam H, Turgunbaev M, Turner AS, and Reston J

Subjects
Child, Humans, United States, Vaccination, Rheumatology, Antirheumatic Agents therapeutic use, Musculoskeletal Diseases drug therapy
Abstract

Objective: To provide evidence-based recommendations on the use of vaccinations in children and adults with rheumatic and musculoskeletal diseases (RMDs)., Methods: This guideline follows American College of Rheumatology (ACR) policy guiding management of conflicts of interest and disclosures and the ACR guideline development process, which includes the Grading of Recommendations Assessment, Development and Evaluation (GRADE) methodology. It also adheres to the Appraisal of Guidelines for Research and Evaluation (AGREE) criteria. A core leadership team consisting of adult and pediatric rheumatologists and a guideline methodologist drafted clinical population, intervention, comparator, outcomes (PICO) questions. A review team performed a systematic literature review for the PICO questions, graded the quality of evidence, and produced an evidence report. An expert Voting Panel reviewed the evidence and formulated recommendations. The panel included adult and pediatric rheumatology providers, infectious diseases specialists, and patient representatives. Consensus required ≥70% agreement on both the direction and strength of each recommendation., Results: This guideline includes expanded indications for some vaccines in patients with RMDs, as well as guidance on whether to hold immunosuppressive medications or delay vaccination to maximize vaccine immunogenicity and efficacy. Safe approaches to the use of live attenuated vaccines in patients taking immunosuppressive medications are also addressed. Most recommendations are conditional and had low quality of supporting evidence., Conclusion: Application of these recommendations should consider patients' individual risk for vaccine-preventable illness and for disease flares, particularly if immunosuppressive medications are held for vaccination. Shared decision-making with patients is encouraged in clinical settings., (© 2023 American College of Rheumatology.)

Published
2023
Full Text
View/download PDF

17. American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 5.

Author

Curtis JR, Johnson SR, Anthony DD, Arasaratnam RJ, Baden LR, Bass AR, Calabrese C, Gravallese EM, Harpaz R, Kroger A, Sadun RE, Turner AS, Williams EA, and Mikuls TR

Subjects
Vaccination, Muscular Diseases, COVID-19 Vaccines therapeutic use, Humans, United States, Musculoskeletal Diseases, COVID-19 prevention & control, Rheumatology, Rheumatic Diseases drug therapy
Abstract

Objective: To provide guidance to rheumatology providers on the use of COVID-19 vaccines for patients with rheumatic and musculoskeletal diseases (RMDs)., Methods: A task force was assembled that included 9 rheumatologists/immunologists, 2 infectious diseases specialists, and 2 public health physicians. After agreeing on scoping questions, an evidence report was created that summarized the published literature and publicly available data regarding COVID-19 vaccine efficacy and safety, as well as literature for other vaccines in RMD patients. Task force members rated their agreement with draft consensus statements on a 9-point numerical scoring system, using a modified Delphi process and the RAND/University of California Los Angeles Appropriateness Method, with refinement and iteration over 2 sessions. Consensus was determined based on the distribution of ratings., Results: Despite a paucity of direct evidence, statements were developed by the task force and agreed upon with consensus to provide guidance for use of the COVID-19 vaccines, including supplemental/booster dosing, in RMD patients and to offer recommendations regarding the use and timing of immunomodulatory therapies around the time of vaccination., Conclusion: These guidance statements are intended to provide direction to rheumatology health care providers on how to best use COVID-19 vaccines and to facilitate implementation of vaccination strategies for RMD patients., (© 2022 American College of Rheumatology.)

Published
2023
Full Text
View/download PDF

18. American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 4.

Author

Curtis JR, Johnson SR, Anthony DD, Arasaratnam RJ, Baden LR, Bass AR, Calabrese C, Gravallese EM, Harpaz R, Kroger A, Sadun RE, Turner AS, Williams EA, and Mikuls TR

Subjects
COVID-19 Vaccines therapeutic use, Humans, Muscular Diseases, United States, Vaccination, COVID-19 prevention & control, Musculoskeletal Diseases, Rheumatic Diseases, Rheumatology
Abstract

Objective: To provide guidance to rheumatology providers on the use of COVID-19 vaccines for patients with rheumatic and musculoskeletal diseases (RMDs)., Methods: A task force was assembled that included 9 rheumatologists/immunologists, 2 infectious disease specialists, and 2 public health physicians. After agreeing on scoping questions, an evidence report was created that summarized the published literature and publicly available data regarding COVID-19 vaccine efficacy and safety, as well as literature for other vaccines in RMD patients. Task force members rated their agreement with draft consensus statements on a 9-point numerical scoring system, using a modified Delphi process and the RAND/University of California Los Angeles Appropriateness Method, with refinement and iteration over 2 sessions. Consensus was determined based on the distribution of ratings., Results: Despite a paucity of direct evidence, statements were developed by the task force and agreed upon with consensus to provide guidance for use of the COVID-19 vaccines, including supplemental/booster dosing, in RMD patients and to offer recommendations regarding the use and timing of immunomodulatory therapies around the time of vaccination., Conclusion: These guidance statements are intended to provide direction to rheumatology health care providers on how to best use COVID-19 vaccines and to facilitate implementation of vaccination strategies for RMD patients., (© 2022 American College of Rheumatology.)

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results